abbvie, graf

custom search

REVERSED
Tech Center 1700 Chemical & Materials Engineering
1735 Ex Parte Hirano et al 12923319 - (D) WILSON 112(1)/103 MICHAEL TOBIAS SAAD, ERIN BARRY

2872 Ex Parte Krull 14176043 - (D) DELMENDO Dissenting HASTINGS 103 HARNESS, DICKEY, & PIERCE, P.L.C PICHLER, MARIN 08/13/2015

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3731 Ex Parte Ellis et al 12882070 - (D) SMITH 103 Sughrue Mion - Abbott (Legacy Evalve) LYNCH, ROBERT A 03/15/2012

3741 Ex Parte Ainslie et al 13410752 - (D) REIMERS 103 Kinney & Lange, P.A. BURKE, THOMAS P

3746 Ex Parte VAN DE WALLE et al 13457518 - (D) CALVE 103 HOYNG ROKH MONEGIER LLP NICHOLS, CHARLES W 09/27/2012

3772 Ex Parte Berndt et al 10466374 - (D) CAPP 103 HENRY M FEIEREISEN, LLC JACKSON, BRANDON LEE

AFFIRMED-IN-PART
2619 Ex Parte Gaiter 14853162 - (D) SILVERMAN 103 103 LNG/RWB Cases MEROUAN, ABDERRAHIN 01/07/2016

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1644 Ex Parte Hawiger et al 10800023 - (D) GRIMES 112(1)/103 NELSON MULLINS RILEY & SCARBOROUGH LLP SCHWADRON, RONALD B

"One needs to show that one has truly invented the genus, i.e., that one has conceived and described sufficient representative species encompassing the breadth of the genus. Otherwise, one has only a research plan, leaving it to others to explore the unknown contours of the claimed genus." AbbVie Deutsch/and GmbH & Co. v. Janssen Biotech, Inc., 759 F.3d 1285, 1300 (Fed. Cir. 2014).

AbbVie Duetschland GmbH & Co., KG v. Janssen Biotech, Inc., 759 F.3d 1285, 111 USPQ2d 1780 (Fed. Cir. 2014)  2163 ,   2163.01 ,   2163.05

1656 Ex Parte Ikeda et al 14119071 - (D) SCHNEIDER 103 OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. GEBREYESUS, KAGNEW H 04/24/2014

Tech Center 1700 Chemical & Materials Engineering
1733 Ex Parte Engler et al 14624793 - (D) OWENS 103 REINHART BOERNER VAN DEUREN P.C. MORILLO, JANELL COMBS

1733 Ex Parte MOULIN et al 13112195 - (D) WILSON 103 SUGHRUE MION, PLLC WYSZOMIERSKI, GEORGE P

1768 Ex Parte Sanchez Reyes et al 13033643 - (D) HASTINGS 103 SCHLUMBERGER TECHNOLOGY CORPORATION LI, AIQUN

1788 Ex Parte Evans et al 13359696 - (D) McGEE 103 ASPEN AEROGELS INC. GOLDEN, CHINESSA T

1789 Ex Parte Lademann et al 12850138 - (D) HASTINGS 103 Greenberg Traurig, LLP PIERCE, JEREMY R

Tech Center 2100 Computer Architecture and Software
2128 Ex Parte Subbu et al 12895293 - (D) DEJMEK 112(2)/103 GENERAL ELECTRIC COMPANY FERNANDEZ RIVAS, OMAR F

"Obviousness is not to be determined on the basis of purpose alone." In re Graf, 343 F.2d 774, 777 (CCPA 1965). 

2142 Ex Parte Yokoi et al 13407342 - (D) SHIANG 101/103 Trellis IP Law Group/Oracle NICHOLS, JENNIFER ELIZABETH-JO

2173 Ex Parte Krishnamurthi 13526888 - (D) PYONIN 102/103 Kilpatrick Townsend & Stockton/Qualcomm GATTEW, ASTEW AY T 06/20/2013

2175 Ex Parte Conroy et al 11895410 - (D) STRAUSS 103 Patent Docketing SUGENT, JAMES F

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2425 Ex Parte DuBose 14503478 - (D) SHIANG 102/103 Meagher Emanuel Laks Goldberg & Liao, LLP CHEN, CAI Y

2438 Ex Parte Dodeja et al 13976861 - (D) PYONIN 103 WOMBLE BOND DICKINSON (US) LLP/Mission PEARSON, DAVID J

Tech Center 2600 Communications
2672 Ex Parte Godewyn et al 14708211 - (D) NAPPI 103 CRGO LAW HANG, VU B

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2824 Ex Parte Grover et al 13456419 - (D) KENNEDY 102 Sheridan Ross P.C. BASHAR, MOHAMMED A

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3629 Ex Parte Stibel et al 13251835 - (D) MOHANTY 101 OHLANDT, GREELEY, RUGGIERO & PERLE, LLP JASMIN, LYNDA C

3673 Ex Parte Fazio 13677666 - (D) OSINSKI 103 CANTOR COLBURN LLP HARE, DAVID R

3683 Ex Parte Travis et al 13781044 - (D) HUME 101/102 41.50 112(2) Cuenot, Forsythe & Kim, LLC LOFTIS, JOHNNA RONEE

3684 Ex Parte Chaturvedi et al 13409767 - (D) MOHANTY 101 Johnson, Marcou & Isaacs, LLC LOHARIKAR, ANAND R

3688 Ex Parte Mehanian et al 13830957 - (D) JEFFERY 102/103 101 SEED INTELLECTUAL PROPERTY LAW GROUP LLP FRUNZI, VICTORIA E.

3691 Ex Parte Fan et al 12147620 - (D) KUMAR 101/103 MICROSOFT CORPORATION PRESTON, JOHN O

3692 Ex Parte Marynowski et al 14828117 - (D) SHAW 101 IP GROUP OF DLA PIPER LLP (US) FELTEN, DANIELS

3695 Ex Parte Scudder et al 14068617 - (D) SILVERMAN 101 LEYDIG VOIT & MAYER, LTD SUBRAMANIAN, NARAYANSWAMY

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3742 Ex Parte FISCHER et al 13687045 - (D) STAICOVICI 103 112(2) MCNEES WALLACE & NURICK LLC CHEN, KUANGYUE

3745 Ex Parte Avellan et al 13519588 - (D) SCHOPPER 103 Bejin Bieneman PLC GKN Aerospace SEHN, MICHAEL L

3749 Ex Parte Ebner et al 12629771 - (D) DOUGAL 103 SHELL OIL COMPANY HERZFELD, NATHANIEL

3781 Ex Parte Jain 13711258 - (D) HILL 103 41.50 103 FOX ROTHSCHILD LLP POOS, MADISON LYNN

REEXAMINATION

REVERSED
Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3694 Ex parte TRADING TECHNOLOGIES INTERNATIONAL, INC. Appellant Ex Parte 7685055 et al 10125894 90013624 - (D) PETRAVICK 103 Polsinelli PC Special Reexam Group THIRD PARTY REQUESTER: SMITH, GAMBRELL & RUSSELL, LLP WORJLOH, JALATEE original GREENE, DANIEL LAWSON NONE

gordon, ariad, abbvie, rochester

custom search

REVERSED
Tech Center 2100 Computer Architecture and Software
2198 Ex Parte LU et al 12103730 - (D) ZADO 102/103 Russell Ng PLLC (IBM AUS) KABIR, MOHAMMAD H

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2431 Ex Parte Hinton 11010228 - (D) KOHUT 102 IBM CORP. (DHJ) c/o DAVID H. JUDSON AVERY, JEREMIAH L

Tech Center 2800 Semiconductors, Electrical and Optical Systems and Components
2842 Ex Parte Houston et al 13116973 - (D) HASTINGS 112(1)/102/103 TEXAS INSTRUMENTS INCORPORATED CHENG, DIANA

Tech Center 3700 Mechanical Engineering, Manufacturing, and Products & Design
3741 Ex Parte Cloft 11823496 - (D) KINDER 103 Kinney & Lange, P.A. KIM, CRAIG SANG

Examining the entirety of each of the prior art references to determine whether it would have been obvious to combine Olsen’s electrically driven oil system into Champion, we conclude it would not because doing so would render Champion unsatisfactory for its intended purpose. See In re Gordon, 733 F.2d 900, 902 (Fed. Cir. 1984).

Gordon, In re, 733 F.2d 900, 221 USPQ 1125 (Fed. Cir. 1984) 2143.01 , 2144.08

AFFIRMED-IN-PART
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2432 Ex Parte Moskowitz 11895388 - (D) DEJMEK 103 103 NEIFELD IP LAW, PC OKEKE, IZUNNA

2491 Ex Parte Viamonte Sole 12144201 - (D) HOMERE 102/103 102/103 RATNERPRESTIA DESROSIERS, EVANS

Tech Center 2600 Communications
2648 Ex Parte Chen et al 12170319 - (D) LENTIVECH 102 102 TEXAS INSTRUMENTS INCORPORATED BILODEAU, DAVID

Tech Center 3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
3672 Ex Parte Freeman 13168621 - (D) PLENZLER 103 102 SCHLUMBERGER-DOLL RESEARCH ANDREWS, DAVID L

AFFIRMED
Tech Center 1600 Biotechnology and Organic Chemistry
1675 Ex Parte Subkowski et al 11922650 - (D) PER CURIUM 112(1)/112(2)/102 112(1) Drinker Biddle & Reath LLP (WM) HA, JULIE

A “generic claim may define the boundaries of a vast genus of chemical compounds, and yet the question may still remain whether the specification, including original claim language, demonstrates that the applicant has invented species sufficient to support a claim to a genus.” Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1349 (Fed. Cir. 2010).

When a patent claims a genus using functional language to define a desired result, “the specification must demonstrate that the applicant has made a generic invention that achieves the claimed result and do so by showing that the applicant has invented species sufficient to support a claim to the functionally-defined genus.” AbbVie Deutschland GmbH & Co., KG v. Janssen Biotech, Inc., 759 F.3d 1285, 1299 (Fed. Cir. 2014) (quoting Ariad, 598 F.3d at 1349).

Ariad Pharms., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 94 USPQ2d 1161 (Fed. Cir. 2010)(en banc) 2161 , 2181

AbbVie Duetschland GmbH & Co., KG v. Janssen Biotech, Inc., 759 F.3d 1285, 111 USPQ2d 1780 (Fed. Cir. 2014)  2163 ,   2163.01 ,   2163.05

The Federal Circuit confronted facts similar to those here in University of Rochester v. G.D. Searle & Co., Inc., 358 F.3d 916 (Fed. Cir. 2004). In that case, the patent claimed a method of selectively inhibiting the enzyme PGHS-2 (also known as COX-2) by “administering a non-steroidal compound that selectively inhibits activity of the PGHS-2 gene product in a human.” Id. at 918. The patent “described in detail how to make cells that express either COX-1 or COX-2, but not both …, as well as ‘assays for screening compounds, including peptides, polynucleotides, and small organic molecules to identify those that inhibit the expression or activity of the PGHS-2 gene product.[’]” Id. at 927.

The court held that the disclosure of screening assays and general classes of compounds was not adequate to describe compounds having the desired activity: without disclosure of which peptides, polynucleotides, or small organic molecules have the desired characteristic, the claims failed to meet the description requirement of § 112. See id. (“As pointed out by the district court, the ‘850 patent does not disclose just ‘which “peptides, polynucleotides, and small organic molecules” have the desired characteristic of selectively inhibiting PGHS-2.’ … Without such disclosure, the claimed methods cannot be said to have been described.”).

University of Rochester v. G.D. Searle & Co., 358 F.3d 916, 69 USPQ2d 1886 (Fed. Cir. 2004) 2163

Tech Center 2100 Computer Architecture and Software
2157 Ex Parte CHAUDHRY 12430761 - (D) McKEOWN 103 THE DIRECTV GROUP, INC. PARK, GRACE A

2167 Ex Parte Wong et al 10888772 - (D) JEFFERY 103 Baker Botts LLP KHAKHAR, NIRAV K

Tech Center 2400 Networking, Multiplexing, Cable, and Security
2485 Ex Parte Baylon 11562517 - (D) DANG 103 ARRIS Group, Inc. TORRENTE, RICHARD T

REHEARING

DENIED
Tech Center 2400 Networking, Multiplexing, Cable, and Security
2444 Ex Parte Haynes et al 12140570 - (D) SHAW 103 CRGO LAW STEVEN M. GREENBERG PAPPAS, PETER